Curious if anyone sees a path for us to succeed here, now that Denner has revealed himself willing to cut his shareholders' throats to get his money back. What happens after the RS? Dilution? Taking the company private for pennies on the dollar? It seems like no one cares about the folks who have invested in the company because they believed in the drug.
I really thought he put $100 million into AMRN because his plan was to get the company ready for a sale. Man was I wrong.
Market Data 
Markets 
AI
